Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Oncoclinicas Do Brasil Servicos Medicos's selling, general, & admin. expense for the
three
months ended in Jun. 2026 was R$315 Mil.
Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2026 was R$1,279 Mil.
Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
Oncoclinicas Do Brasil Servicos Medicos Selling, General, & Admin. Expense Related Terms
Oncoclinicas Do Brasil Servicos Medicos Selling, General, & Admin. Expense Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oncoclinicas Do Brasil Servicos Medicos Selling, General, & Admin. Expense Chart
Oncoclinicas Do Brasil Servicos Medicos Annual Data
BSP:ONCO3 vs HCA, THC, EHC: Selling, General, & Admin. Expense Comparison
For the Medical Care Facilities subindustry, Oncoclinicas Do Brasil Servicos Medicos's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oncoclinicas Do Brasil Servicos Medicos Selling, General, & Admin. Expense vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oncoclinicas Do Brasil Servicos Medicos's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where Oncoclinicas Do Brasil Servicos Medicos's Selling, General, & Admin. Expense falls into.
Oncoclinicas Do Brasil Servicos Medicos Selling, General, & Admin. Expense Calculation
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1,279 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Selling, General, & Admin. Expense of R$1,279 Mil mean?
Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) has a Selling, General, & Admin. Expense of R$1,279 Mil as of Jun. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Oncoclinicas Do Brasil Servicos Medicos and its competitors.
Is Oncoclinicas Do Brasil Servicos Medicos' Selling, General, & Admin. Expense too high?
Oncoclinicas Do Brasil Servicos Medicos' current Selling, General, & Admin. Expense is R$1,279 Mil. Overall, Oncoclinicas Do Brasil Servicos Medicos has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oncoclinicas Do Brasil Servicos Medicos' Selling, General, & Admin. Expense compare to HCA and THC?
Oncoclinicas Do Brasil Servicos Medicos' Selling, General, & Admin. Expense of R$1,279 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Healthcare Providers & Services company?
A good Selling, General, & Admin. Expense depends on the Healthcare Providers & Services industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Oncoclinicas Do Brasil Servicos Medicos and its competitors. Oncoclinicas Do Brasil Servicos Medicos's current Selling, General, & Admin. Expense is R$1,279 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoclinicas Do Brasil Servicos Medicos stock overvalued right now?
Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$3.38, compared to a current price of R$1.08 — trading 68% below its estimated fair value. The current Selling, General, & Admin. Expense is R$1,279 Mil. Oncoclinicas Do Brasil Servicos Medicos' overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3), the current Selling, General, & Admin. Expense is R$1,279 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Overvalued in 2026?
Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos stock appears to be undervalued.
The current stock price of R$1.08 is trading 68% below its estimated GF Value™ of R$3.38.
GuruFocus considers Oncoclinicas Do Brasil Servicos Medicos to be Possible Value Trap.
Key valuation signals for BSP:ONCO3:
Selling, General, & Admin. Expense: R$1,279 Mil
GF Value™: R$3.38 vs. price of R$1.08 (68% below fair value)
No single metric tells the full story. See the BSP:ONCO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology, and bone marrow transplantation, complementary care. The Group operates solely in the healthcare services segment, with an emphasis on oncology.
46GF Score
Get the complete analysis for BSP:ONCO3
Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:ONCO3 has been successfully added to your 
